Catheter Precision, Inc.
VTAK
$0.4101
$0.02526.55%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -27.82% | -3.13% | -3.53% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -27.82% | -3.13% | -3.53% | -- | -- |
| Cost of Revenue | 66.67% | 128.57% | -50.00% | -- | -- |
| Gross Profit | -32.28% | -13.48% | 2.67% | -- | -- |
| SG&A Expenses | 4.99% | 91.73% | -74.04% | -65.71% | -21.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.21% | 80.59% | -74.26% | -66.41% | -32.49% |
| Operating Income | -4.73% | -86.10% | 74.84% | 67.99% | 35.63% |
| Income Before Tax | -113.80% | -167.77% | 95.97% | 91.80% | 59.54% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -113.80% | -167.77% | 95.97% | 91.80% | 59.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -113.80% | -167.77% | 95.97% | 91.80% | 59.54% |
| EBIT | -4.73% | -86.10% | 74.84% | 67.99% | 35.63% |
| EBITDA | -5.38% | -348.98% | 76.61% | 74.28% | 46.96% |
| EPS Basic | 29.05% | -89.66% | 98.54% | 97.52% | 93.51% |
| Normalized Basic EPS | 29.05% | -191.35% | 90.48% | 97.49% | 92.67% |
| EPS Diluted | 29.01% | -89.66% | 98.54% | 97.52% | 93.51% |
| Normalized Diluted EPS | 29.05% | -191.35% | 90.48% | 97.49% | 92.67% |
| Average Basic Shares Outstanding | 201.34% | 41.18% | 172.52% | 230.47% | 523.26% |
| Average Diluted Shares Outstanding | 201.34% | 41.18% | 172.52% | 230.47% | 523.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
